Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
idiotguru's Profile
Displaying 1-21 of 21 result(s).
ONCI On4 Communications
03/20/2019 2:38:27 PM
This is flippin exhilarating to say
ONCI On4 Communications
03/15/2019 2:24:39 PM
Can someone explain "Retained Earni
ONCI On4 Communications
02/26/2019 2:50:31 PM
Awfully *
ONCI On4 Communications
02/26/2019 2:47:59 PM
You're being awful polite to get th
ONCI On4 Communications
02/25/2019 9:20:16 AM
I'm curious what would serve us bes (1)
ONCI On4 Communications
02/07/2019 10:25:26 AM
After hours today
ONCI On4 Communications
02/07/2019 8:34:21 AM
As long as we are rhyming our way t
ONCI On4 Communications
01/09/2019 8:39:06 AM
Mr. Idiotguru would like some meat (1)
ONCI On4 Communications
12/31/2018 4:36:42 PM
Why the typos in the articles of in
ONCI On4 Communications
09/28/2018 2:12:57 PM
I mean, should I buy more?
ONCI On4 Communications
06/28/2018 11:42:29 AM
Got myself some 28s and finally cra (2)
ONCI On4 Communications
06/07/2018 10:04:34 PM
I still have the utmost faith that
ONCI On4 Communications
05/18/2018 11:25:12 AM
I'm gonna go hang some drywall. All
ONCI On4 Communications
05/14/2018 10:22:39 AM
Yeah I don't think many people refe
ONCI On4 Communications
04/30/2018 5:43:59 PM
I'm with you buddy.
ONCI On4 Communications
04/30/2018 5:40:12 PM
If you're responding to me, I don't
ONCI On4 Communications
04/30/2018 5:13:11 PM
I honestly have no idea what's goin
ONCI On4 Communications
04/30/2018 5:01:47 PM
Maybe they mean 'so on' and are mis
ONCI On4 Communications
04/30/2018 4:52:31 PM
I don't mean to be nitpicky but jmo
ONCI On4 Communications
04/29/2018 3:49:55 PM
I gave up on it as well. Too much s (1)
ONCI On4 Communications
04/19/2018 8:37:34 PM
I ain't selling sheeeeeeeeeeeeeeeee (1)

Recent Articles

  • ProKidney Set to Present Novel CKD Research at Kidney Week
  • Altimmune Reveals Exciting Data on Pemvidutide at AASLD 2025
  • Sanofi’s Tzield Advances Towards US Approval for Type 1 Diabetes
  • Radiopharm Theranostics Secures A$35 Million Placement Funds
  • Mutuum Finance Prepares Major Launch with 17,300 Investors
  • Consolidated Lithium Metals: Upcoming Webinar Highlights
  • QuickTopUps.com Expands Digital Services in MENAP Region
  • b.well Partners with Google to Enhance Personalized Health
  • SciSparc and Clearmind's Collaborative Patent on Binge Behavior Care
  • BriaCell Unveils Promising Phase 3 Biomarkers at ESMO 2025
  • Revolutionary Patent Application by Clearmind Advances Mental Health Solutions
  • Image Specialty Partners Welcomes New Executives to Boost Growth
  • Canadian Entrepreneurs Remain Resilient in Changing Times
  • Exploring the AI as a Service Market: Growth and Insights
  • BingX Academy 2.0: Empowering Users in Web3 Education
  • Exploring the Depth Sensing Market's Incredible Growth Potential
  • Exciting Developments in Gold Mining at Cármenes Project
  • Pan Global Expands Drilling Efforts in Cármenes Gold Project
  • Future Trends in the Expanding Analytical Chemistry Sector
  • Nicely Network Emerges as Leading Reddit Marketing Agency
  • Robotics Market Expected to Surge to USD 200 Billion in Coming Years
  • Empowering Health Data Management with b.well and Google
  • Ituran Location and Control to Release Q3 Results on Nov 18
  • Endo Introduces Groundbreaking Generic Glycerol Phenylbutyrate Liquid
  • Radiopharm Theranostics Engages in Major Funding Round of A$40M
  • Siipet Unveils Innovative AI Tool for Cat Health Monitoring
  • Sandstorm Gold Successfully Completes Arrangement with Royal Gold
  • Sanofi’s Tzield Awaits FDA Review for Phase 3 Diabetes Treatment
  • Horizon Copper Finalizes Arrangement with Royal Gold Success
  • Blaqclouds, Inc. Moves Forward with FinCEN MSB Application
  • Altimmune to Reveal New Data on Pemvidutide at Major Conference
  • CorMedix Inc. Boosts Revenue Predictions with Q3 Highlights
  • Engage with Consolidated Lithium Metals' Corporate Insights
  • ProKidney's Major Step in Chronic Kidney Disease Treatment Announced
  • Innovative AI-Powered Solutions for the Industrial Sector
  • Aventis Energy Unveils Promising Uranium Assay Results
  • PMGC Holdings Builds Strong Momentum with $711K Sales Backlog
  • BriaCell Unveils Pivotal Biomarker Study Findings at ESMO
  • Churchill Resources Uncovers Significant Findings at Frost Cove Mine
  • Christina Lake Cannabis Secures Credit and Equipment Lease
  • Enzo Villani to Address Ethical Innovation at World Summit
  • Replimune's BLA Resubmission for RP1 Advances Cancer Treatment
  • AI Maverick Intel Transitions to AIMV Ticker for Future Growth
  • In-Depth Overview of EMPAVELI Efficacy in Kidney Diseases
  • Strategic Leadership Growth at Stella-Jones Inc. Board
  • Exciting Progress in Clinical Trials for Innovative MS Treatment
  • BPGbio and Mount Sinai's Study Offers New Hope for Neurodegenerative Diseases
  • Key Additions to Stella-Jones Board Enhance Strategic Vision
  • Understanding Schouw & Co.'s Share Buy-Back Programme 2025
  • J-Star Embraces Nasdaq's Collaboration for Vietnam's Financial Hub
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site